Another population-based study showed that out of 832 diabetic patients with novel coronavirus disease, the 263 patients who were taking DPP-4 inhibitors showed 64% less severe symptoms of COVID-19 than non-users [47]. The gene discussed is DPP4; the disease is COVID-19.